Ask three research suppliers for a quote on tesamorelin and you can get three numbers that differ by a factor of three. That spread is not random. It tracks a handful of concrete cost drivers — sequence length, synthesis difficulty, analytical testing, and where the material was made — and once you understand those, the “tesamorelin peptide cost” question becomes easy to answer for any given quote.
This article breaks the price down for laboratory buyers sourcing tesamorelin as a research-use-only compound.
What you’re paying for
Tesamorelin is a 44-amino-acid synthetic analogue of growth-hormone-releasing hormone (GHRH), with a trans-3-hexenoic acid modification at the N-terminus that improves stability against enzymatic breakdown. Two properties of that description set the price floor:
Length. Solid-phase peptide synthesis adds residues one at a time, and every coupling step has a yield slightly under 100%. A 44-residue chain compounds those losses; crude yield is meaningfully lower than for a 10- or 15-residue peptide, and purification to research grade discards more material. Tesamorelin will always cost more per milligram than short peptides, regardless of vendor.
The N-terminal modification. The hexenoyl group is an extra synthetic step and an extra thing to verify by mass spectrometry. Suppliers who skip proper identity confirmation can shave cost here — and ship something that isn’t tesamorelin.
What the market actually charges
Research-grade tesamorelin is sold almost exclusively in 10 mg lyophilized vials (5 mg and 20 mg exist but are less common). Observed 2026 price bands from US vendors that publish certificates of analysis:
| Vial size | Typical price band | Per mg |
|---|---|---|
| 5 mg | $70–$110 | $14–$22 |
| 10 mg | $95–$180 | $9.50–$18 |
| 20 mg | $180–$320 | $9–$16 |
The lower end of each band is generally domestic direct-to-buyer suppliers with published batch testing; the upper end is either resellers adding a margin or vendors bundling “kits.” For a concrete anchor, the tesamorelin peptide cost at HEEZ Research is $115 for a 10 mg vial with a third-party COA published per lot — near the bottom of the tested-material band.
Quotes well below $90 for 10 mg deserve scepticism rather than celebration. At that price something in the chain has usually been cut: under-filled vials, purity below research grade, or no lot-level testing at all.
Why quotes vary so much
Testing is the biggest swing. Third-party HPLC purity plus mass-spec identity on every lot adds real cost per batch. Vendors that test every lot price it in. Vendors that test one lot a year — or reuse a raw-material supplier’s paperwork — don’t. The cheaper quote is often the untested one.
Country of synthesis. Bulk peptide from overseas contract manufacturers is cheaper than domestic synthesis, but chain-of-custody, storage conditions in transit and re-testing on arrival vary enormously. Some US vendors do re-test imported material; many don’t. “US-made” and “US-shipped” are different claims — ask which one a supplier is making.
Net peptide content. A 10 mg label can mean 10 mg gross fill (peptide plus counter-ions and excipients) or 10 mg of peptide. The difference is often 15–25%. Two vendors at the same sticker price may differ that much in what’s actually in the vial, and only the one publishing net content on the COA lets you check.
Volume tiers. Most suppliers discount at three or five vials. If you’re buying for a research program rather than a single experiment, the per-mg cost at the tier price is the number to compare, not the single-vial price.
A quick cost-per-mg sanity check
When comparing quotes:
- Confirm the vial size refers to peptide content, not gross fill.
- Divide the tier price you’d actually pay by milligrams.
- Add a penalty for any vendor that cannot produce a lot-specific COA with HPLC chromatogram and MS identity — because untested material is not the same product at any price.
- Add shipping. Domestic same-day dispatch usually lands cheaper and safer than a discounted international parcel that spends ten days in transit.
A $115 vial with a published COA and next-day domestic delivery routinely beats a $79 vial with none of those once the risk of receiving the wrong compound, or short weight, is priced in.
Where prices are heading
Demand for tesamorelin in research settings has increased steadily, but so has domestic synthesis capacity, and per-mg prices for tested material have been flat to slightly down over the past year. The trend to watch is not price but testing transparency: buyers increasingly expect a downloadable COA per lot, and suppliers that provide it — HEEZ Research publishes batch certificates for every product — are setting the standard the rest of the market is being pulled toward.
